- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis in America Medical Cannabis Access for Pain Treatment
- Join Join
Becoming a Patient in Kentucky
Under SB 124, a patient can become a patient simply by obtaining a written order for CBD from a physician practicing at a hospital or associated clinic affiliated with a Kentucky public university having a college or school of medicine.
Alternatively, one can also be a patient in Kentucky by participating in a clinical trial or in an expanded access program, in which case the patient receives a drug or substance approved for the use of those participants by the United States Food and Drug Administration.
However, the law is short and vague, and does not provide any more guidance than that.
Only CBD or a drug approved for use of participants in a clinical trial by the United States Food or Drug Administration are legal under SB 124. Products with trace amounts of other cannabinoids, such as THC, CBG, CBN, and any of the other non-CBD cannabinoids that exist in cannabis and cannabis based products are not legal.
The law does not place any limitations on qualifying conditions.
There is no application process; however, patients may only legally obtain and possess CBD if they have been given a written order from an eligible physician.
Patients may only obtain a written order from a physician practicing at a hospital or associated clinic affiliated with a Kentucky public university having a college or school of medicine
The law does not grant legal protections for caregivers.
The law does not place restrictions on where patients may use CBD.
There are no age restrictions under SB 124.
There is no patient registry under SB 124. Physicians must adhere HIPPA rules regarding confidentiality of patient records.
The law does not offer housing protections for patients.
The law does not offer employment protections for patients.
The law is silent on whether health insurance must cover patient access to CBD products in Kentucky.
Out of State patients
The law does not address out of state patients. Only patients with a written order from a physician practicing at a hospital or associated clinic affiliated with a Kentucky public university having a college or school of medicine may possess CBD in Kentucky, but the law does not specify that they must be residents of Kentucky.
For More Information
Project CBD - Does not contain specific information about Kentucky law, but provides more information on CBD therapy.